Efficacy of Secretin Assisted Dynamic MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis(AIP)
Phase of Trial: Phase IV
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Secretin (Primary)
- Indications Pancreatitis
- Focus Diagnostic use
- Acronyms S-MRCP
- 30 Jan 2018 Planned End Date changed from 1 Apr 2014 to 1 Dec 2018.
- 30 Jan 2018 Planned primary completion date changed from 1 Feb 2014 to 1 Dec 2018.
- 15 May 2015 New trial record